SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma.

Nong, Jusen; Yang, Kejian; Li, Tianman; Lan, Chenlu; Zhou, Xin; Liu, Junqi; Xie, Haixiang; Luo, Jianzhu; Liao, Xiwen; Zhu, Guangzhi; Peng, Tao

Nong, Jusen; Yang, Kejian; Li, Tianman; Lan, Chenlu; Zhou, Xin; Liu, Junqi; Xie, Haixiang; Luo, Jianzhu; Liao, Xiwen; Zhu, Guangzhi; Peng, Tao.

Afiliação

Nong J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China.
Yang K; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Ministry of Education, Nanning 530021, People’s Republic of China.
Li T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China.
Lan C; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Ministry of Education, Nanning 530021, People’s Republic of China.
Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China.
Liu J; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Ministry of Education, Nanning 530021, People’s Republic of China.
Xie H; Department of Hepatobiliary Surgery, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin 537000, People’s Republic of China.
Luo J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China.
Liao X; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Ministry of Education, Nanning 530021, People’s Republic of China.
Zhu G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China.
Peng T; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Ministry of Education, Nanning 530021, People’s Republic of China.

Aging (Albany NY) ; 15(16): 8408-8432, 2023 08 24.

Article em En | MEDLINE | ID: mdl-37632835

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Proteína Supressora de Tumor p53; China; Prognóstico; Biomarcadores; Antígenos de Neoplasias; Proteínas de Ligação a RNA

Palavras-chave

TP53 mutation; hepatocellular carcinoma (HCC); immune checkpoint; immune infiltration; prognosis; squamous cell carcinoma antigen recognized by T cells 3 (SART3)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Aging (Albany NY) Assunto da revista: GERIATRIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google